A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19
Background: Limited literature exists on Cerebrospinal fluid (CSF) findings in COVID-19 patients with neurological symptoms. In this review, we conducted a descriptive analysis of CSF findings in patients with COVID-19 to understand prognosis and explore therapeutic options. Methods: We searched PubMed, Google Scholar, and Scopus databases using the keywords “SARS-CoV-2 in cerebrospinal fluid” and “SARS-CoV-2 and CNS Complications”'' for reports of CSF findings in COVID-19 related neurological manifestations. Descriptive analyses were conducted to observe the CSF protein and cell counts based on age, gender, severity, fatality of COVID-19, and whether central (CNS) or peripheral nervous system (PNS) was associated. Results: A total of 113 patients were identified from 67 studies. Of these, 7 patients (6.2%) were fatal COVID-19 cases and 35 patients (31%) were considered severe COVID-19 cases. CSF protein was elevated in 100% (7/7) of the fatal cases with an average of 61.28 mg/dl and in 65.0% (52/80) in non-fatal cases with an average 56.73 mg/dl. CSF protein levels were elevated in 74.5% (38/51) patients with non-severe COVID-19 and 68.6% (24/35) in those with a severe COVID-19 infection. CSF cell count was increased in 43% of fatal cases, 25.7% severe cases, and 29.4% of non-severe cases. Conclusion: Our analysis showed that the most common CSF findings situation in COVID-19 infection is elevated protein with, very occasionally, mild lymphocyte predominant pleocytosis. Further studies to elucidate the pathophysiology of neurological complications in COVID-19 are recommended..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:104 |
|---|---|
| Enthalten in: |
International Journal of Infectious Diseases - 104(2021), Seite 390-397 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Medha Tandon [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
COVID-19 |
|---|
| doi: |
10.1016/j.ijid.2021.01.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ056798288 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ056798288 | ||
| 003 | DE-627 | ||
| 005 | 20230308204058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2021.01.002 |2 doi | |
| 035 | |a (DE-627)DOAJ056798288 | ||
| 035 | |a (DE-599)DOAJ50fc11528f064d2a9a7a2d808fe01b2b | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC109-216 | |
| 100 | 0 | |a Medha Tandon |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: Limited literature exists on Cerebrospinal fluid (CSF) findings in COVID-19 patients with neurological symptoms. In this review, we conducted a descriptive analysis of CSF findings in patients with COVID-19 to understand prognosis and explore therapeutic options. Methods: We searched PubMed, Google Scholar, and Scopus databases using the keywords “SARS-CoV-2 in cerebrospinal fluid” and “SARS-CoV-2 and CNS Complications”'' for reports of CSF findings in COVID-19 related neurological manifestations. Descriptive analyses were conducted to observe the CSF protein and cell counts based on age, gender, severity, fatality of COVID-19, and whether central (CNS) or peripheral nervous system (PNS) was associated. Results: A total of 113 patients were identified from 67 studies. Of these, 7 patients (6.2%) were fatal COVID-19 cases and 35 patients (31%) were considered severe COVID-19 cases. CSF protein was elevated in 100% (7/7) of the fatal cases with an average of 61.28 mg/dl and in 65.0% (52/80) in non-fatal cases with an average 56.73 mg/dl. CSF protein levels were elevated in 74.5% (38/51) patients with non-severe COVID-19 and 68.6% (24/35) in those with a severe COVID-19 infection. CSF cell count was increased in 43% of fatal cases, 25.7% severe cases, and 29.4% of non-severe cases. Conclusion: Our analysis showed that the most common CSF findings situation in COVID-19 infection is elevated protein with, very occasionally, mild lymphocyte predominant pleocytosis. Further studies to elucidate the pathophysiology of neurological complications in COVID-19 are recommended. | ||
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Oligoclonal bands | |
| 650 | 4 | |a CSF Protein | |
| 650 | 4 | |a CSF cell count | |
| 653 | 0 | |a Infectious and parasitic diseases | |
| 700 | 0 | |a Saurabh Kataria |e verfasserin |4 aut | |
| 700 | 0 | |a Jenil Patel |e verfasserin |4 aut | |
| 700 | 0 | |a Tejas R Mehta |e verfasserin |4 aut | |
| 700 | 0 | |a Maha Daimee |e verfasserin |4 aut | |
| 700 | 0 | |a Viral Patel |e verfasserin |4 aut | |
| 700 | 0 | |a Apoorv Prasad |e verfasserin |4 aut | |
| 700 | 0 | |a Anisa Anila Chowdhary |e verfasserin |4 aut | |
| 700 | 0 | |a Shruti Jaiswal |e verfasserin |4 aut | |
| 700 | 0 | |a Shitiz Sriwastava |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 104(2021), Seite 390-397 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
| 773 | 1 | 8 | |g volume:104 |g year:2021 |g pages:390-397 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2021.01.002 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/50fc11528f064d2a9a7a2d808fe01b2b |z kostenfrei |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971221000035 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 104 |j 2021 |h 390-397 | ||